阿片类药物定居点:成医学在指导有效支出方面的作用
Sara Whaley1, Josh Sharfstein, Josh Rising
1From the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (SW, JS); and Rising Health Strategies, Washington, DC (JR).
Journal of addiction medicine
|November 7, 2023
概括
阿片类药物解决方案为国家补救提供了数十亿美元,与过去的烟草基金不同. 成专家可以指导有效投资阿片类药物使用障碍方案.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 成 药物 药物 药物 药物
背景情况:
- 阿片类药物诉讼为各州带来了大量资金,估计在18年内达到560亿美元.
- 与以前的烟草和解协议不同,阿片类药物和解协议要求大多数资金针对阿片类药物补救工作.
- 然而,国家和地方当局仍然在计划的具体情况和质量方面拥有重要的自由裁量权.
研究的目的:
- 强调成医学专家有机会影响阿片类药物结算资金的分配.
- 强调专家指导在确保有效的阿片类药物补救计划方面的重要性.
主要方法:
- 对阿片类药物结算条款和融资结构的分析.
- 确定在州和地方一级分配资金的关键决策点.
- 审查成医学专业知识在计划开发和监督中的潜在作用.
主要成果:
- 阿片类药物结算基金是专门用于整治的,在国家层面对支出进行了实质性的控制.
- 药物成专家处于一个独特的位置,能够为基于证据的计划设计和实施提供信息.
- 有效地利用专业知识可以最大限度地提高和解基金对阿片类药物使用障碍的影响.
结论:
- 阿片类药物结算基金为推进阿片类药物使用障碍公共卫生倡议提供了关键的机会.
- 药物成专家的专业知识对于将这些资金用于有影响力和基于证据的干预措施至关重要.
- 专家的战略参与可以确保问责制,并优化阿片类药物补救工作的结果.
相关概念视频
Analgesia and Pain Management
634
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
634
Drug Abuse and Addiction: Pharmacological Phenomena
489
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
489
Opioid Analgesics: Synthetic and Semisynthetic Opioids
310
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
310
Opioid Analgesics: Morphine and Other Natural Cogeners
262
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Substance Use Disorders Affecting Sleep
174
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
174
Drug Control Governance: Regulatory Bodies and Their Impact
163
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
163


